Comparison of core needle biopsy and fine-needle aspiration methods in CT-guided percutaneous sampling of pancreatic tumors
To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. A total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. Th...
Saved in:
Published in | Journal of cancer research and therapeutics Vol. 19; no. 4; pp. 904 - 909 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Mumbai
Medknow Publications and Media Pvt. Ltd
01.08.2023
Medknow Publications & Media Pvt. Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. A total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. They were divided into three groups: FNA group A (<1.5 cm between the lesion and great vessels necessitating FNA), FNA group B, and CNB (the latter two with ≥1.5 cm between the lesion and great vessels necessitating FNA). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and postoperative. The statistical analysis was done using Statistical Package for the Social Sciences version 17.0. One hundred and seventy six patient's specimens all met the requirements. There were no statistically significant differences in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the CNB group and FNA group B, (P > 0.05). Thirteen samples submitted for genetic testing (5 in CNB group, 4 in each of the FNA groups A and B) all met the standards of next-generation sequencing gene detection. The main complications of these groups included abdominal pain, fever, and hyperamylasemia. CT-guided percutaneous FNA and CNB have similar diagnostic efficacy for pancreatic biopsy. Furthermore, FNA has a wide range of puncture indications and is very safe. Like CNB, the obtained tissue through FNA can be genetically tested to guide clinical treatment. |
---|---|
AbstractList | ABSTRACTAims:To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions.Methods and Material:A total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. They were divided into three groups: FNA group A (<1.5 cm between the lesion and great vessels necessitating FNA), FNA group B, and CNB (the latter two with ≥1.5 cm between the lesion and great vessels necessitating FNA). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and postoperative. The statistical analysis was done using Statistical Package for the Social Sciences version 17.0.Results:One hundred and seventy six patient’s specimens all met the requirements. There were no statistically significant differences in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the CNB group and FNA group B, (P > 0.05). Thirteen samples submitted for genetic testing (5 in CNB group, 4 in each of the FNA groups A and B) all met the standards of next-generation sequencing gene detection. The main complications of these groups included abdominal pain, fever, and hyperamylasemia.Conclusions:CT-guided percutaneous FNA and CNB have similar diagnostic efficacy for pancreatic biopsy. Furthermore, FNA has a wide range of puncture indications and is very safe. Like CNB, the obtained tissue through FNA can be genetically tested to guide clinical treatment. To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. A total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. They were divided into three groups: FNA group A (<1.5 cm between the lesion and great vessels necessitating FNA), FNA group B, and CNB (the latter two with ≥1.5 cm between the lesion and great vessels necessitating FNA). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and postoperative. The statistical analysis was done using Statistical Package for the Social Sciences version 17.0. One hundred and seventy six patient's specimens all met the requirements. There were no statistically significant differences in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the CNB group and FNA group B, (P > 0.05). Thirteen samples submitted for genetic testing (5 in CNB group, 4 in each of the FNA groups A and B) all met the standards of next-generation sequencing gene detection. The main complications of these groups included abdominal pain, fever, and hyperamylasemia. CT-guided percutaneous FNA and CNB have similar diagnostic efficacy for pancreatic biopsy. Furthermore, FNA has a wide range of puncture indications and is very safe. Like CNB, the obtained tissue through FNA can be genetically tested to guide clinical treatment. ABSTRACT Aims: To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. Methods and Material: A total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. They were divided into three groups: FNA group A (<1.5 cm between the lesion and great vessels necessitating FNA), FNA group B, and CNB (the latter two with ≥1.5 cm between the lesion and great vessels necessitating FNA). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and postoperative. The statistical analysis was done using Statistical Package for the Social Sciences version 17.0. Results: One hundred and seventy six patient's specimens all met the requirements. There were no statistically significant differences in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the CNB group and FNA group B, (P > 0.05). Thirteen samples submitted for genetic testing (5 in CNB group, 4 in each of the FNA groups A and B) all met the standards of next-generation sequencing gene detection. The main complications of these groups included abdominal pain, fever, and hyperamylasemia. Conclusions: CT-guided percutaneous FNA and CNB have similar diagnostic efficacy for pancreatic biopsy. Furthermore, FNA has a wide range of puncture indications and is very safe. Like CNB, the obtained tissue through FNA can be genetically tested to guide clinical treatment. Keywords: Aspiration biopsy, CT-guided fine needle, genetic testing, pancreatic neoplasms AimsTo compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. Methods and MaterialA total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. They were divided into three groups: FNA group A (<1.5 cm between the lesion and great vessels necessitating FNA), FNA group B, and CNB (the latter two with ≥1.5 cm between the lesion and great vessels necessitating FNA). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and postoperative. The statistical analysis was done using Statistical Package for the Social Sciences version 17.0. ResultsOne hundred and seventy six patient's specimens all met the requirements. There were no statistically significant differences in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the CNB group and FNA group B, (P > 0.05). Thirteen samples submitted for genetic testing (5 in CNB group, 4 in each of the FNA groups A and B) all met the standards of next-generation sequencing gene detection. The main complications of these groups included abdominal pain, fever, and hyperamylasemia. ConclusionsCT-guided percutaneous FNA and CNB have similar diagnostic efficacy for pancreatic biopsy. Furthermore, FNA has a wide range of puncture indications and is very safe. Like CNB, the obtained tissue through FNA can be genetically tested to guide clinical treatment. |
Audience | Professional |
Author | Liu, Jingjing Wang, Shenjie Huang, Wei Wang, Ziyin Wu, Zhiyuan Wang, Zhongmin Ding, Xiaoyi |
Author_xml | – sequence: 1 fullname: Liu, Jingjing – sequence: 2 fullname: Huang, Wei – sequence: 3 fullname: Wang, Shenjie – sequence: 4 fullname: Wu, Zhiyuan – sequence: 5 fullname: Wang, Ziyin – sequence: 6 fullname: Ding, Xiaoyi – sequence: 7 fullname: Wang, Zhongmin |
BookMark | eNptkkFrGzEQhUVJoE7aH9CboJde1tFIWks6BtOmhUAu6VnI0qwrsyttpN1D6J_vOg40LWZgBobvPQbmXZGLlBMS8gnYWgITNwdfpvWxWeCGWc7fkRUYoxsJQl-QFTNKNCA1f0-uaj0w1irO9Yr83uZhdCXWnGjuqM8FaUIMPdJdzGN9pi4F2sWEzeva1TEWN8VFMOD0K4dKY6Lbx2Y_x4CBjlj8PLmEea60umHsY9ofvUeXfMFF6ek0D7nUD-Syc33Fj6_zmvz89vVx-725f7j7sb29b7xs5dRsguIQvA7tZueZDsA1MwZB7VrHpN9hcFL4VhgFLVdSdppBkCi90p3hXolr8uXkO5b8NGOd7BCrx74_HWm53nAwmut2QT__hx7yXNJynRUAIIXSrfpL7V2PNqYuT8X5o6m91aA5E8bAQjVnqD0mLK5fvtfFZf0Pvz7DLxVwiP6sAE4CX3KtBTs7lji48myB2WMq7Esg3qZC_AEY2a6D |
CitedBy_id | crossref_primary_10_4103_jcrt_jcrt_1761_23 |
Cites_doi | 10.1097/00004728-200209000-00014 10.4103/jcrt.JCRT_1663_20 10.1002/jcu.22362 10.3748/wjg.v21.i12.3579 10.4103/jcrt.JCRT_803_20 10.1007/s00280-015-2788-6 10.1016/S1470-2045(19)30691-6 10.1016/j.clinimag.2014.06.010 10.1093/annonc/mdx343 10.4103/jcrt.JCRT_755_18 10.3322/caac.21551 10.1016/j.jvir.2010.01.011 10.4103/jcrt.JCRT_408_18 10.6004/jnccn.2019.0014 10.6004/jnccn.2021.0017 10.2214/AJR.05.0366 10.1016/j.carj.2018.10.014 10.1007/s00330-015-4003-x 10.3748/wjg.v19.i15.2368 10.1200/JCO.19.02105 10.1056/NEJMoa1903387 10.1016/S0140-6736(20)30974-0 10.4103/jcrt.JCRT_563_20 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2023 Medknow Publications and Media Pvt. Ltd. 2023. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: COPYRIGHT 2023 Medknow Publications and Media Pvt. Ltd. – notice: 2023. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION K9. 7X8 |
DOI | 10.4103/jcrt.jcrt_1290_22 |
DatabaseName | CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1998-4138 |
EndPage | 909 |
ExternalDocumentID | A818203991 10_4103_jcrt_jcrt_1290_22 |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- 29K 2WC 3V. 53G 5GY 5VS 7X7 88E 8FI 8FJ 8G5 AAWTL AAYXX ABDBF ABJNI ABUWG ABXLX ACGFS ADBBV AENEX AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION D-I DIK DU5 DWQXO E3Z EBD EBS EJD EMOBN EOJEC ESX F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 H13 HMCUK IAO IEA IHE IHR IL9 INH INR IOF IPNFZ IPO ITC KQ8 M1P M2O M~E OBODZ OK1 OVD P2P P6G PIMPY PQQKQ PROAC PSQYO RBI RIG RMW RNS SV3 TEORI TR2 TUS UKHRP W3E XSB ~8M K9. 7X8 |
ID | FETCH-LOGICAL-c454t-6d721dc8d56bc08d128099e17b5a04cbeda43c5397152744f801d4e4c78f92c73 |
ISSN | 0973-1482 |
IngestDate | Wed Dec 04 02:50:54 EST 2024 Thu Dec 05 14:35:11 EST 2024 Thu Dec 05 14:59:49 EST 2024 Thu Dec 05 17:33:28 EST 2024 Thu Dec 05 09:30:37 EST 2024 Fri Dec 06 07:07:47 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c454t-6d721dc8d56bc08d128099e17b5a04cbeda43c5397152744f801d4e4c78f92c73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doi.org/10.4103/jcrt.jcrt_1290_22 |
PQID | 3111437857 |
PQPubID | 226490 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2862198285 proquest_journals_3111437857 gale_infotracmisc_A818203991 gale_infotracgeneralonefile_A818203991 gale_infotracacademiconefile_A818203991 crossref_primary_10_4103_jcrt_jcrt_1290_22 |
PublicationCentury | 2000 |
PublicationDate | 2023-08-00 20230801 |
PublicationDateYYYYMMDD | 2023-08-01 |
PublicationDate_xml | – month: 08 year: 2023 text: 20230801 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Mumbai |
PublicationPlace_xml | – name: Mumbai |
PublicationTitle | Journal of cancer research and therapeutics |
PublicationYear | 2023 |
Publisher | Medknow Publications and Media Pvt. Ltd Medknow Publications & Media Pvt. Ltd |
Publisher_xml | – sequence: 0 name: Medknow Publications and Media Pvt. Ltd – sequence: 0 name: Medknow Publications & Media Pvt. Ltd |
References | Matsuyama (R9-20241021) 2013; 19 Gai (R4-20241021) 2021; 17 Yang (R11-20241021) 2015; 39 Tyng (R16-20241021) 2015; 21 Karabulut (R25-20241021) 2020; 16 Tempero (R7-20241021) 2021; 19 Gupta (R14-20241021) 2010; 21 Zech (R12-20241021) 2002; 26 Stella (R8-20241021) 2019; 70 Marabelle (R23-20241021) 2020; 38 Kahriman (R13-20241021) 2016; 44 Zhu (R6-20241021) 2019; 15 Mizrahi (R1-20241021) 2020; 395 Yang (R2-20241021) 2021; 17 Sohal (R18-20241021) 2020; 5 Putnik (R17-20241021) 2001; 58 Siegel (R5-20241021) 2019; 69 Golan (R21-20241021) 2019; 381 Doebele (R24-20241021) 2020; 21 Tempero (R26-20241021) 2019; 17 Paulsen (R15-20241021) 2006; 187 Fogelman (R22-20241021) 2015; 76 D'Onofrio (R10-20241021) 2016; 26 Wei (R3-20241021) 2021; 17 Schultheis (R20-20241021) 2017; 28 (R19-20241021) 2021 |
References_xml | – volume: 26 start-page: 743 year: 2002 ident: R12-20241021 article-title: Large core biopsy of thepancreas under CT fluoroscopy control:Results and complications publication-title: J Comput Assist Tomogr doi: 10.1097/00004728-200209000-00014 contributor: fullname: Zech – volume: 17 start-page: 613 year: 2021 ident: R3-20241021 article-title: Chinese expert consensus of image-guided irreversible electroporation for pancreatic cancer publication-title: J Cancer Res Ther doi: 10.4103/jcrt.JCRT_1663_20 contributor: fullname: Wei – volume: 58 start-page: 357 year: 2001 ident: R17-20241021 article-title: Complications in percutaneous aspiration biopsy of thepancreas publication-title: Vojnosanit Pregl contributor: fullname: Putnik – volume: 44 start-page: 470 year: 2016 ident: R13-20241021 article-title: Percutaileous ultrasound-guided core needle biopsy of solid pancreatic massses:Results in 250 patients publication-title: J Clin Ultrasound doi: 10.1002/jcu.22362 contributor: fullname: Kahriman – volume: 21 start-page: 3579 year: 2015 ident: R16-20241021 article-title: Computed tomography-guided percutaneous core needle biopsy in pancreatic tumor diagnosis publication-title: World J Gastroenterol doi: 10.3748/wjg.v21.i12.3579 contributor: fullname: Tyng – volume: 17 start-page: 702 year: 2021 ident: R4-20241021 article-title: Advantages of interstitial radioactive seed implantation for the treatment of Stage III pancreatic cancer publication-title: J Cancer Res Ther doi: 10.4103/jcrt.JCRT_803_20 contributor: fullname: Gai – volume: 76 start-page: 489 year: 2015 ident: R22-20241021 article-title: Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-015-2788-6 contributor: fullname: Fogelman – volume: 21 start-page: 271 year: 2020 ident: R24-20241021 article-title: Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours:Integrated analysis of three phase 1-2 trials publication-title: Lancet Oncol doi: 10.1016/S1470-2045(19)30691-6 contributor: fullname: Doebele – volume: 39 start-page: 62 year: 2015 ident: R11-20241021 article-title: Evaluation of percutaneous ultrasound-guided biopsies of solid mass lesions of the pancreas:A center's 10-year experience publication-title: Clin Imaging doi: 10.1016/j.clinimag.2014.06.010 contributor: fullname: Yang – volume: 28 start-page: 2429 year: 2017 ident: R20-20241021 article-title: Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer:A multicenter, randomized phase IIb study publication-title: Ann Oncol doi: 10.1093/annonc/mdx343 contributor: fullname: Schultheis – volume: 16 start-page: 110 year: 2020 ident: R25-20241021 article-title: Circulating annexin A2 as a biomarker in patients with pancreatic cancer publication-title: J Cancer Res Ther doi: 10.4103/jcrt.JCRT_755_18 contributor: fullname: Karabulut – volume: 69 start-page: 7 year: 2019 ident: R5-20241021 article-title: Cancer statistics, 2019 publication-title: CA Cancer J Clin doi: 10.3322/caac.21551 contributor: fullname: Siegel – volume: 21 start-page: 969 year: 2010 ident: R14-20241021 article-title: Quality improvement guidelines for percutaneous needle biopsy publication-title: J Vasc Interv Radiol doi: 10.1016/j.jvir.2010.01.011 contributor: fullname: Gupta – volume: 15 start-page: 831 year: 2019 ident: R6-20241021 article-title: High-intensity focused ultrasound ablation for advanced pancreatic cancer publication-title: J Cancer Res Ther doi: 10.4103/jcrt.JCRT_408_18 contributor: fullname: Zhu – volume: 5 year: 2020 ident: R18-20241021 article-title: Metastatic pancreatic cancer:ASCO guideline update publication-title: J Clin Oncol contributor: fullname: Sohal – volume: 17 start-page: 202 year: 2019 ident: R26-20241021 article-title: Pancreatic Adenocarcinoma. version 1.2019 publication-title: J Narl Compr Canc Netw doi: 10.6004/jnccn.2019.0014 contributor: fullname: Tempero – volume: 19 start-page: 439 year: 2021 ident: R7-20241021 article-title: Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology publication-title: J Natl Compr Cancer Netw doi: 10.6004/jnccn.2021.0017 contributor: fullname: Tempero – volume: 187 start-page: 769 year: 2006 ident: R15-20241021 article-title: Evaluation of imaging-guided core biopsy of pancreatic mass publication-title: AJR Am Roentgenol doi: 10.2214/AJR.05.0366 contributor: fullname: Paulsen – volume: 70 start-page: 199 year: 2019 ident: R8-20241021 article-title: Image-guided percutaneous biopsy for pancreatic lesions:10-year experience in a tertiary cancer center publication-title: Can Assoc Radiol J doi: 10.1016/j.carj.2018.10.014 contributor: fullname: Stella – year: 2021 ident: R19-20241021 publication-title: Pancreatic adenocarcinoma – volume: 26 start-page: 1801 year: 2016 ident: R10-20241021 article-title: Ultrasound-guided percutaneous fine-needle aspiration of solid pancreatic neoplasms:10-year experience with more than 2,000 cases and a review of the literature publication-title: Eur Radiol doi: 10.1007/s00330-015-4003-x contributor: fullname: D'Onofrio – volume: 19 start-page: 2368 year: 2013 ident: R9-20241021 article-title: Ultrasound-guided vs endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer diagnosis publication-title: World J Gastroenterol doi: 10.3748/wjg.v19.i15.2368 contributor: fullname: Matsuyama – volume: 38 start-page: 1 year: 2020 ident: R23-20241021 article-title: Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/mismatch repair-deficient cancer:Results from the phase 2 KEYNOTE-158 study publication-title: J Clin Oncol doi: 10.1200/JCO.19.02105 contributor: fullname: Marabelle – volume: 381 start-page: 317 year: 2019 ident: R21-20241021 article-title: Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1903387 contributor: fullname: Golan – volume: 395 start-page: 2008 year: 2020 ident: R1-20241021 article-title: Pancreatic cancer publication-title: Lancet doi: 10.1016/S0140-6736(20)30974-0 contributor: fullname: Mizrahi – volume: 17 start-page: 720 year: 2021 ident: R2-20241021 article-title: The clinical efficacy of computed tomography-guided 125I particle implantation combined with arterial infusion chemotherapy in the treatment of pancreatic cancer publication-title: J Cancer Res Ther doi: 10.4103/jcrt.JCRT_563_20 contributor: fullname: Yang |
SSID | ssj0057228 |
Score | 2.3622618 |
Snippet | ABSTRACT Aims: To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic... To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. A... ABSTRACTAims:To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic... AimsTo compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions.... |
SourceID | proquest gale crossref |
SourceType | Aggregation Database |
StartPage | 904 |
SubjectTerms | Biopsy Biopsy, Needle Care and treatment Comparative analysis CT imaging Methods Pancreatic tumors |
Title | Comparison of core needle biopsy and fine-needle aspiration methods in CT-guided percutaneous sampling of pancreatic tumors |
URI | https://www.proquest.com/docview/3111437857 https://search.proquest.com/docview/2862198285 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKJiFeEAwQhVEZCQ2JLFuTOF-PoxpMiE0V6kTFS5Q4zpoK2qpNkAp_hp_Kvbbz0a4Pg5eoSlIn8j2xj-1zjwl5E7OA2VZmwYckXJOFMTNDL4jNILFEP3F8YByYKHx55V1cs09jd9zp_GmplsoiOeG_duaV_E9U4RzEFbNk_yGydaFwAn5DfOEIEYbjnWI8aG8iaKAhpTGD3ui7MJJ8vlgpa6UMeKSpT8dqXR1DrraOlmrYwci8KfMUqOdCLHkJdFGgMHYVo9pci6IBHJJecqMof8z1EtBtUssRREtDWwhNKn1mleJVE_jPeSnxA8VPq85TgktPX38VeTPVr2e0J2I2zZulJFnAt0m-LjXA9dyF7dTKOa1f2sr4k9I_qS_BrBlj-LM4aYmb5KSl75joXLrRfoctnLJWYxyqjY23Owlm9dGsYsqXUE9wiHAqLlLZ0Vve22cB-tsDh4Px9T5aLeLuDB_HtYjI9W25e2_9XmrdHJ9weqv8Deazu_-XpGb0iDzUgaNnClqPSUfMDsj9S623OCBHQ-Vsvj6mo1YUj-kRHTae5-sn5HcDRTrPKEKRKsxRBUUKFU5bUKQNFKmGIs1ntIYibUORVlDEshsoUgXFp-T6w_locGHqfT1MzlxWmF7q21bKg9T1Et4PUqBIME4Rlp-4cZ_xRKQxc7gLTBn3XGYsAxaVMsG4H2ShzX3nGdmbzWfiOaFWFroiCGLXFSnjoRML20187gnoZuzUs7rkXVXn0ULZt0Qw7MUARTI27QB1yVuMSoRgKZYxj3WGCjwKTdKiBg1dcrRx542yiN914-HGjdB2883LFQAi3a6sIgfoB3P8wPW75HV9Gf-JekhZ7ZEdeEA10H3yxV1f5SV50HyCh2SvWJbiFRDqIumRe_7Y75H99-dXwy89ifC_6ZXX8g |
link.rule.ids | 314,780,784,27924,27925,31719,31720,33744,33745 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+core+needle+biopsy+and+fine-needle+aspiration+methods+in+CT-guided+percutaneous+sampling+of+pancreatic+tumors&rft.jtitle=Journal+of+cancer+research+and+therapeutics&rft.au=Liu%2C+Jingjing&rft.au=Huang%2C+Wei&rft.au=Wang%2C+Shenjie&rft.au=Wu%2C+Zhiyuan&rft.date=2023-08-01&rft.pub=Medknow+Publications+and+Media+Pvt.+Ltd&rft.issn=0973-1482&rft.volume=19&rft.issue=4&rft.spage=904&rft_id=info:doi/10.4103%2Fjcrt.jcrt_1290_22&rft.externalDocID=A818203991 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0973-1482&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0973-1482&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0973-1482&client=summon |